Skip to main content

ERRATUM article

Front. Genet., 19 December 2023
Sec. Computational Genomics

Erratum: Integrated weighted gene co-expression network analysis identified that TLR2 and CD14 are related to coronary artery disease

  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Integrated weighted gene co-expression network analysis identified that TLR2 and CD14 are related to coronary artery disease

by Qi B, Chen J-H, Tao L, Zhu C-M, Wang Y, Deng G-X and Miao L (2021). Front. Genet. 11:613744. doi: 10.3389/fgene.2020.613744

In the published article there was an error in the article title. Instead of “Integrated Weighted Gene Co-expression Network Analysis Identified That TLR2 and CD40 Are Related to Coronary Artery Disease”, it should be “Integrated Weighted Gene Co-expression Network Analysis Identified That TLR2 and CD14 Are Related to Coronary Artery Disease.”

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: gene expression omnibus, integrated weighted gene co-expression network analysis, functional enrichment, functional validation, prognostic analysis, coronary artery disease

Citation: Frontiers Production Office (2023) Erratum: Integrated weighted gene co-expression network analysis identified that TLR2 and CD14 are related to coronary artery disease. Front. Genet. 14:1347174. doi: 10.3389/fgene.2023.1347174

Received: 30 November 2023; Accepted: 30 November 2023;
Published: 19 December 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.